Ray Dalio’s Sanofi SNY Stock Holding History

Ray Dalio’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.83M	Buy	+206,873	New	+$9.24M	0.04%	357

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Ray Dalio's SNY Position: Q2 2026 in Review

Ray Dalio opened a new position in Sanofi (SNY) in Q2 2026: 206,873 shares worth $8.83M. The stake represents 0.04% of the portfolio and ranks #357 among its holdings.

719 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Ray Dalio held 206,873 shares of Sanofi worth $8.83M as of Q2 2026.
Sanofi was a new Ray Dalio position in Q2 2026.
Sanofi made up 0.04% of Ray Dalio's portfolio in Q2 2026, its #357 holding.
719 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.